Benzinga | Aug 5, 2021 05:59AM EDT

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $38

SVB Leerink analyst Mani Foroohar maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $41 to $38.